Factors characterizing access and latency to first pharmacological treatment in Italian patients with schizophrenia, mood, and anxiety spectrum disorders-Reference-Cited by-同舟云学术

Factors characterizing access and latency to first pharmacological treatment in Italian patients with schizophrenia, mood, and anxiety spectrum disorders

Published:2015-01 Issue:1 Volume:30 Page:29-35
ISSN:0268-1315
Container-title:International Clinical Psychopharmacology
language:en
Short-container-title:International Clinical Psychopharmacology

Author:

Dell’Osso Bernardo,Cremaschi Laura,Palazzo Carlotta,Suardi Neva,Spagnolin Gregorio,Camuri Giulia,Benatti Beatrice,Oldani Lucio,Dobrea Cristina,Arici Chiara,Pace Giovanna,Tiseo Alessandra,Nahum Ester Sembira,Castellano Filippo,D’Urso Nazario,Clerici Massimo,Primavera Diego,Carpiniello Bernardo,Altamura A. Carlo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference4 articles.

1. On reducing the duration of untreated illness in unipolar depression

2. The Burden of Mood Disorders

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Which clinical factors delay proper treatment in panic disorder? A cross‐sectional multicentric study;Early Intervention in Psychiatry;2024-02-15

2. Latency to selective serotonin reuptake inhibitor vs benzodiazepine treatment in patients with panic disorder: a naturalistic study;CNS Spectrums;2021-11-05

3. Exploring characteristics associated with first benzodiazepine prescription in patients with affective disorders and related diagnoses;Human Psychopharmacology: Clinical and Experimental;2019-05

4. A new tool to assess duration of untreated illness: Psychopathological Onset and Latency to Treatment Questionnaire (POLT-Q);RIV PSICHIATR;2018

5. Health service utilization and medical costs among patients with schizophrenia receiving long-acting injectable risperidone versus oral risperidone;International Clinical Psychopharmacology;2018-07